U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

1,1,1-TRIS(4-HYDROXYPHENYL)ETHANE

MORE DETAILS

25K43J16E2

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

PENTAERYTHRITOL

MORE DETAILS

  SU420W1S6N

Status:
Possibly Marketed Outside US
Source:
WHO-ATC:A06AD14
Source URL:
https://ginas.ncats.nih.gov/ginas/app/substance/SU420W1S6N
First approved in 2005
Source:
ANDA077109
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14766ad1-d61d-4838-92e1-849a929f4dbd
Class (Stereo):
CHEMICAL (ACHIRAL)
Pentaerythritol is an inactive metabolite of pentaerythritol tetranitrate, a drug that is used for the treatment of angina pectoris.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966